Interventional Oncology A Multidisciplinary Approach to Image-Guided Cancer Therapy
Language: English
Published by Springer, 2026
- Hardcover
- New
Condition: New
£ 1,034.23
Quantity: 2 available
Add to basketItem description from seller
This is a bold new text on image-guided cancer therapy bringing together the expertise and experience of interventional radiologists, surgeons, pulmonologists, gastroenterologists, radiation oncologists and diagnostic imagers in treating patients with cancer. This multidisciplinary guide provides detailed description of cutting-edge techniques that have transformed how tumors are diagnosed, targeted, palliated, and treated. Whether learning the basics of patient evaluation or refining procedural skills, this book is an essential reference for clinicians of all specialties pushing the frontier of personalized image-guided cancer treatment.The growth in this field has been greatly aided by technological improvements in ablative tools, imaging, and image-guided navigation. Practitioners of IO are a large workforce in most modern hospitals, responsible for a large number of patients daily. Understanding concepts underlying IO procedures, as well as devices and procedures available, is essential for all who participate in the care of the cancer patient.This book is a state-of-the-art overview of IO and is authored by the scientists and clinicians who have pioneered the field. Overall, it summarizes the history, current technology, common procedures, and future prospects in the field. It includes procedures from many surgical and interventional radiologic disciplines because 1) it aims to be definitive, and 2) often procedures are performed partly in interventional radiology and partly in the surgical suite. This new edition includes 20 new chapters and delves deeper into specific treatment methods and practice guidelines.The book is separated into three main sections with multiple parts. In the first, the history and technical principles that underlie tumor ablation are presented. The second part discusses current imaging modalities used for guidance of these procedures and monitoring of their effectiveness. Included in this section are considerations of workflow, OR/IR architecture, and financial issues revolving around IO. The book then moves on to organ-specific applications of IO, including 1) primary liver cancer, 2) metastatic tumors to the liver, 3) lung tumors, 4) renal tumors, 5) prostate tumors, 6) bone tumors, and 7) miscellaneous tumors. The currently available equipment and equipment anticipated in the near future, special populations, and illustrations of the most common procedures are also included.This book is intended to summarize the field for cancer interventionalists and surgeons at all levels. This field being highly collaborative, the authors of chapters in this book are from many disciplines, making this a definitive text on the theory and practice of IO relevant to all clinicians interested in cancer therapy. Sprache: Englisch Gewicht in Gramm: 2142.…
Seller Inventory # IB-69129
- Title
- Interventional Oncology A Multidisciplinary Approach to Image-Guided Cancer Therapy
- Publisher
- Springer
- Publication year
- 2026
- Condition
- Neu
- Binding
- Gebundene Ausgabe
- Language
- English
- ISBN 10
- 3031497619
- ISBN 13
- 9783031497612
- Edition
- 2nd Edition
- Item weight
- 2,142 grams
This is a bold new text on image-guided cancer therapy bringing together the expertise and experience of interventional radiologists, surgeons, pulmonologists, gastroenterologists, radiation oncologists and diagnostic imagers in treating patients with cancer. This multidisciplinary guide provides detailed description of cutting-edge techniques that have transformed how tumors are diagnosed, targeted, palliated, and treated. Whether learning the basics of patient evaluation or refining procedural skills, this book is an essential reference for clinicians of all specialties pushing the frontier of personalized image-guided cancer treatment.
The growth in this field has been greatly aided by technological improvements in ablative tools, imaging, and image-guided navigation. Practitioners of IO are a large workforce in most modern hospitals, responsible for a large number of patients daily. Understanding concepts underlying IO procedures, as well as devices and procedures available, is essential for all who participate in the care of the cancer patient.
This book is a state-of-the-art overview of IO and is authored by the scientists and clinicians who have pioneered the field. Overall, it summarizes the history, current technology, common procedures, and future prospects in the field. It includes procedures from many surgical and interventional radiologic disciplines because 1) it aims to be definitive, and 2) often procedures are performed partly in interventional radiology and partly in the surgical suite. This new edition includes 20 new chapters and delves deeper into specific treatment methods and practice guidelines.
The book is separated into three main sections with multiple parts. In the first, the history and technical principles that underlie tumor ablation are presented. The second part discusses current imaging modalities used for guidance of these procedures and monitoring of their effectiveness. Included in this section are considerations of workflow, OR/IR architecture, and financial issues revolving around IO. The book then moves on to organ-specific applications of IO, including 1) primary liver cancer, 2) metastatic tumors to the liver, 3) lung tumors, 4) renal tumors, 5) prostate tumors, 6) bone tumors, and 7) miscellaneous tumors. The currently available equipment and equipment anticipated in the near future, special populations, and illustrations of the most common procedures are also included.
This book is intended to summarize the field for cancer interventionalists and surgeons at all levels. This field being highly collaborative, the authors of chapters in this book are from many disciplines, making this a definitive text on the theory and practice of IO relevant to all clinicians interested in cancer therapy.
"Synopsis" may belong to another edition of this title.
About the Author
Yuman Fong
City of Hope National Medical Center, Duarte, CA, USA
Dr. Yuman Fong is Chairman of Surgery at the City of Hope Medical Center.
He is known clinically for his extensive workin the field of liver and pancreatic surgery―especially for pioneering many laparoscopic, robotic, and ablative therapies for hepatobiliary cancers. He is best known for work that helped prove liver resection to be potentially curative for stage IV colorectal liver metastases. For his clinical accomplishments, he was awarded the Layton F. Rikkers Master Clinician Award from the Society of Surgery for the Alimentary Tract.
He has also been active in biologic bench investigation. He was part of the group that discovered tumor necrosis factor and helped establish the field of innate immunity. His laboratory focus over the last 25 years has been in the field of gene therapy, designing and studying the use of genetically modified viruses and immune cells for the killing of cancer. His group was the first to administer recombinant viruses into the blood stream of man as a cancer treatment. His leadership in this field has included serving as the Chair of the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health. His work in engineering has led to his election to the American Institute of Medical and Biologic Engineering.
He has co-authored over 1000 articles and 20 textbooks, which have been cited over 100,000 times. He has served on the editorial boards of 28 journals, and was founding Editor-in-Chief of Molecular Therapy Oncology (Cell Press, official journal of the ASGCT).
He has also been awarded the Stanley Dudrick Award from the American Society of Parenteral and Enteral Nutrition, the Shipley Award from the Southern Surgical Association, and the Flance-Karl Award from the American Surgical Association.He has been elected to the American Society of Clinical Investigation, and the National Academy of Medicine.
In his free time, he enjoys skiing, music, and ballroom dancing.
Anne Covey
Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Anne Covey, MD, FSIR, is an Attending Radiologist at Memorial Sloan Kettering Cancer Center (MSKCC) and Professor of Radiology at Weill Cornell Medical College. She received her Bachelor of Science degree from Cornell University,followed by her Doctor of Medicine from Columbia University College of Physicians and Surgeons. She subsequently completed her internship, diagnostic radiology residency, and fellowship in interventional radiology at Yale New Haven Hospital.
She is a recognized authority in interventional oncology, with expertise in locoregional therapies for primary hepatic malignancies and in complex biliary interventions. She is a Fellow of the Society of Interventional Radiology and has held numerous leadership roles within national professional societies. Her prior service includes membership on the hepatobiliary panel of the National Comprehensive Cancer Network (NCCN) and Section Editor for the American Journal of Roentgenology (AJR). She has served as a Trustee of the American Board of Radiology (ABR) since 2017, and in 2024 was elected to the Board of Directors of the Radiological Society of North America (RSNA), where she serves as Liaison for Public Information, Professionalism, and Sustainability.
She has published over 125 peer-reviewed manuscripts, 50 book chapters and review articles, and 2 textbooks.
Jonathan Kessler
Associate Clinical Professor, Department of Diagnostic Radiology, Chief, Division of Interventional Radiology, City of Hope National Medical Center, Duarte, California, USA
Dr. Jonathan Kessler is Associate Clinical Professor and Chief of the Division of Interventional Radiology at City of Hope National Medical Center, where he has practiced since 2012. Board certified in both diagnostic and interventional radiology, he specializes in minimally invasive, image-guided therapies for cancer. His clinical expertise includes embolization and ablation for tumors of the liver, lung, kidney, and bone, as well as advanced procedures to alleviate cancer-related pain, such as vertebral augmentation, bone tumor ablation, and nerve ablation.
He received his B.A. summa cum laude from Yeshiva University and his medical degree from the University of Pennsylvania, where he was elected to Alpha Omega Alpha. He completed his residency in diagnostic radiology and fellowship in vascular and interventional radiology at the University of California, Los Angeles.
He has served on several national and institutional committees such as the Society of Interventional Oncology Education Committee and the Americas Hepato-Pancreato-Biliary Association Research Committee. An active researcher, he has authored numerous peer-reviewed publications, book chapters, and abstracts on interventional oncology, liver-directed therapies, and multidisciplinary cancer care. He is a frequent lecturer and invited speaker at national and international meetings, with presentations spanning hepatobiliary malignancies, neuroendocrine tumors, and liver-directed therapies.
David A. Iannitti
Sr. Chief, Division of Hepatopancreatobiliary (HPB) Surgery, Atrium Health, Charlotte, North Carolina, USA.
Professor of Surgery, Wake Forest School of Medicine, Charlotte, North Carolina, USA
David A. Iannitti is Chief of the Division of HPB Surgery at Atrium Health and Professor of Surgery at the Wake Forest School of Medicine.
He received his medical degree through the Dartmouth–Brown Program in Medicine and completed his general surgery residency at Brown University. He went on to complete a fellowship in liver transplantation and hepatobiliary surgery at the Cleveland Clinic in Cleveland, Ohio.
He began his academic career in 1997 at Brown University, where he co-developed one of the earliest radiofrequency ablation programs in collaboration with Dr. Damian Dupuy. His work helped establish liver tumor ablation as a viable clinical therapy, initially with radiofrequency and later with microwave ablation
technologies. In 2006, he joined Carolinas Medical Center (Atrium Health) in Charlotte, North Carolina, where he founded the Division of HPB Surgery and served as ProgramDirector of an AHPBA-accredited HPB Surgery Fellowship.
Internationally recognized for his expertise in minimally invasive HPB surgery and surgical tumor ablation, Dr. Iannitti has been a leader in the development, refinement, and education of novel ablative technologies. He has played a central role in the evolution of microwave ablation and irreversible electroporation (IRE), and co-led research into the next-generation highfrequency irreversible electroporation (H-FIRE) technology through an NIH R01 grant. He also pioneered the development of advanced image guidance systems and holds multiple patents related to surgical innovation.
He has served in leadership positions across numerous professional societies, including the American College of Surgeons (ACS), the Americas Hepato-Pancreato-Biliary Association (AHPBA), the International Laparoscopic Liver Society (ILLS), the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), and the Society of Surgical Oncology (SSO). He has received more than 70 research grants, including NIH funding, authored over 250 peerreviewed publications and 24 book chapters, and delivered more than 500 scientific presentations and 450 invited lectures worldwide. He serves as international teaching faculty of Institut de Recherche contre les Cancers de l’Appareil Digestif (IRCAD).
Widely regarded as a global thought leader and educator in minimally invasive approaches to liver and pancreas surgery, Dr. Iannitti has significantly advanced the field of surgical oncology through his pioneering work in surgical ablation and image-guided interventions as well as surgical education.
Damian E. Dupuy
Director of Tumor Ablation, Department of Radiology, Cape Cod Healthcare, Hyannis, MA, USA
Adjunct Professor, Brown University, Providence, RI, USA
Damian E. Dupuy, MD, FACR, is a pioneering force in the realm of diagnostic imaging and interventional oncology, specifically imageguided tumor ablation. He currently is an Adjunct Professor at Brown University and is Director of Tumor Ablation at Cape Cod Hospital. With a remarkable career spanning three decades, he has consistently demonstrated his expertise in clinical research, medical devices, radiology, and oncology.
"About the title" may belong to another edition of this title.
Shipping rates from Germany to U.S.A.
| Item | 10 to 12 business days | 8 to 10 business days |
|---|---|---|
| First item | £ 59.32 | £ 89.36 |
Payment methods
- Check
Specialty
BuchRight of withdrawal
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to Home-set, Mannheim, Germany, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
- The delivery of newspapers, journals or magazines with the exception of subscription contracts; and
- The supply of digital content which is not supplied on a tangible medium (e.g. on a CD or DVD) if you accepted when you placed your order that we could start to deliver it, and that you could not withdraw once delivery had started.